{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:27:25Z","timestamp":1770985645351,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/iae.0000000000000476","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T20:29:49Z","timestamp":1422995389000},"page":"1401-1406","source":"Crossref","is-referenced-by-count":45,"title":["ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS"],"prefix":"10.1097","volume":"35","author":[{"given":"Claudine E.","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mrejen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan V.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Sorenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Bailey","family":"Freund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.","volume":"95","author":"Good","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R2-15-20210130","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00417-008-0819-2","article-title":"Persistent ocular hypertension following intravitreal ranibizumab.","volume":"246","author":"Bakri","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R3-15-20210130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3928\/15428877-20090430-12","article-title":". Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections.","volume":"40","author":"Kahook","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R4-15-20210130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/jop.2009.0076","article-title":"Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections.","volume":"26","author":"Adelman","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"R5-15-20210130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/IJG.0b013e31820d7d19","article-title":". Sustained increased intraocular pressure related to intravitreal anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.","volume":"21","author":"Tseng","year":"2012","journal-title":"J Glaucoma"},{"key":"R6-15-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10792-010-9410-z","article-title":"Sustained ocular hypertension following intravitreal injections of 0.5 mg0.05 ml ranibizumab.","volume":"31","author":"Loukianou","year":"2011","journal-title":"Int Ophthalmol"},{"key":"R7-15-20210130","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/IAE.0b013e318217ffde","article-title":". Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.","volume":"31","author":"Choi","year":"2011","journal-title":"Retina"},{"key":"R8-15-20210130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ophtha.2011.08.011","article-title":". Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.","volume":"119","author":"Hoang","year":"2012","journal-title":"Ophthalmology"},{"key":"R9-15-20210130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/IAE.0b013e318261a6f7","article-title":". Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.","volume":"33","author":"Hoang","year":"2013","journal-title":"Retina"},{"key":"R10-15-20210130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2005.07.053","article-title":"Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection.","volume":"141","author":"Hariprasad","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R11-15-20210130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajo.2006.08.033","article-title":". Short-term intraocular pressure trends after intravitreal triamcinolone injection.","volume":"143","author":"Lee","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R12-15-20210130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/IAE.0b013e3180592ba6","article-title":"Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin).","volume":"27","author":"Falkenstein","year":"2007","journal-title":"Retina"},{"key":"R13-15-20210130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ophtha.2005.10.061","article-title":". Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.","volume":"113","author":"Benz","year":"2006","journal-title":"Ophthalmology"},{"key":"R14-15-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.eye.6702938","article-title":". Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.","volume":"23","author":"Bakri","year":"2009","journal-title":"Eye (London)"},{"key":"R15-15-20210130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ajo.2008.07.007","article-title":"Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.","volume":"146","author":"Kim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R16-15-20210130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajo.2014.04.029","article-title":". Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.","volume":"158","author":"Yannuzzi","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R17-15-20210130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/IAE.0000000000000039","article-title":"Influence of axial length and post-injection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy.","volume":"34","author":"Hoang","year":"2014","journal-title":"Retina"},{"key":"R18-15-20210130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/jop.2010.0082","article-title":". Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection.","volume":"27","author":"Rodigues","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"R19-15-20210130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.eye.6702514","article-title":". The use of 31-gauge needles and syringes for intraocular injections.","volume":"21","author":"Pulido","year":"2007","journal-title":"Eye (London)"},{"key":"R20-15-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3928\/23258160-20131105-06","article-title":". Assessment of novel quarded needle to increase patient comfort and decrease injection time during intravitreal injection.","volume":"44","author":"Eaton","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R21-15-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ajo.2007.01.035","article-title":". Tunneled scleral incision to prevent vitreal reflux after intravitreal injection.","volume":"143","author":"Rodigues","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R22-15-20210130","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/IAE.0b013e3181aade74","article-title":". Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort.","volume":"29","author":"Knecht","year":"2009","journal-title":"Retina"},{"key":"R23-15-20210130","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/IAE.0000000000000098","article-title":". Volume and composition of reflux after intravitreal injection.","volume":"34","author":"Brodie","year":"2014","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:07:58Z","timestamp":1620954478000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201507000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000476","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}